Risbridger GP - Search Results

1

Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.

McGrath MJ, Binge LC, Sriratana A, Wang H, Robinson PA, Pook D, Fedele CG, Brown S, Dyson JM, Cottle DL, Cowling BS, Niranjan B, Risbridger GP, Mitchell CA. McGrath MJ, et al. Among authors: risbridger gp. Cancer Res. 2013 Aug 15;73(16):5066-79. doi: 10.1158/0008-5472.CAN-12-4520. Epub 2013 Jun 25. Cancer Res. 2013. PMID: 23801747

2

Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer.

Thomas TZ, Wang H, Niclasen P, O'Bryan MK, Evans LW, Groome NP, Pedersen J, Risbridger GP. Thomas TZ, et al. Among authors: risbridger gp. J Clin Endocrinol Metab. 1997 Nov;82(11):3851-8. doi: 10.1210/jcem.82.11.4374. J Clin Endocrinol Metab. 1997. PMID: 9360551

3

Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145.

McPherson SJ, Thomas TZ, Wang H, Gurusinghe CJ, Risbridger GP. McPherson SJ, et al. Among authors: risbridger gp. J Endocrinol. 1997 Sep;154(3):535-45. doi: 10.1677/joe.0.1540535. J Endocrinol. 1997. PMID: 9379131

4

Expression of activin A and follistatin core proteins by human prostate tumor cell lines.

McPherson SJ, Mellor SL, Wang H, Evans LW, Groome NP, Risbridger GP. McPherson SJ, et al. Among authors: risbridger gp. Endocrinology. 1999 Nov;140(11):5303-9. doi: 10.1210/endo.140.11.7141. Endocrinology. 1999. PMID: 10537161

5

The role of inhibins and activins in prostate cancer pathogenesis.

Dowling CR, Risbridger GP. Dowling CR, et al. Among authors: risbridger gp. Endocr Relat Cancer. 2000 Dec;7(4):243-56. doi: 10.1677/erc.0.0070243. Endocr Relat Cancer. 2000. PMID: 11174846 Review.

6

The metaplastic effects of estrogen on mouse prostate epithelium: proliferation of cells with basal cell phenotype.

Risbridger GP, Wang H, Frydenberg M, Cunha G. Risbridger GP, et al. Endocrinology. 2001 Jun;142(6):2443-50. doi: 10.1210/endo.142.6.8171. Endocrinology. 2001. PMID: 11356693

7

Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland.

McPherson SJ, Wang H, Jones ME, Pedersen J, Iismaa TP, Wreford N, Simpson ER, Risbridger GP. McPherson SJ, et al. Among authors: risbridger gp. Endocrinology. 2001 Jun;142(6):2458-67. doi: 10.1210/endo.142.6.8079. Endocrinology. 2001. PMID: 11356695

8

Regulation of prostate branching morphogenesis by activin A and follistatin.

Cancilla B, Jarred RA, Wang H, Mellor SL, Cunha GR, Risbridger GP. Cancilla B, et al. Among authors: risbridger gp. Dev Biol. 2001 Sep 1;237(1):145-58. doi: 10.1006/dbio.2001.0364. Dev Biol. 2001. PMID: 11518512 Free article.

9

The in vivo effect of red clover diet on ventral prostate growth in adult male mice.

Risbridger GP, Wang H, Frydenberg M, Husband A. Risbridger GP, et al. Reprod Fertil Dev. 2001;13(4):325-9. doi: 10.1071/rd00129. Reprod Fertil Dev. 2001. PMID: 11800171

10

Oestrogens and prostate cancer.

Risbridger GP, Bianco JJ, Ellem SJ, McPherson SJ. Risbridger GP, et al. Endocr Relat Cancer. 2003 Jun;10(2):187-91. doi: 10.1677/erc.0.0100187. Endocr Relat Cancer. 2003. PMID: 12790781 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

275 results

Search Page